CC
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Extrafollicular CD19lowCXCR5−CD11c− double negative 3 (DN3) B cells are significantly associated with disease activity in females with systemic lupus erythematosus | Journal of translational autoimmunity | 2024 | 142 | 69 | |||
| IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermis | Rheumatology | 2022 | 327 | 5 | |||
| Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity | Annals of the rheumatic diseases | 2022 | 9 | 327 | |||
| Urinary incontinence in systemic sclerosis: a prospective multicentre cohort study | Rheumatology international | 2022 | 165 | 78 | |||
| Dysfunctional keratinocytes increase dermal inflammation in systemic sclerosis. Results from tissue-engineered scleroderma epidermis | Arthritis and Rheumatology | 2021 | 415 | 726 | |||
| Native/citrullinated LL37-specific T-cells help autoantibody production in systemic lupus erythematosus | Scientific Reports | 2020 | 357 | 162 | |||
| Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort | Rheumatology | 2020 | 308 | 0 | |||
| RB139, RB140, RB141 and RB142 antibodies recognize human citrullinated LL37 by ELISA | Antibody Reports | 2020 | 293 | 189 | |||
| RB137 recognizes LL37 in neutrophil-extracellular trap-like (NET) structures in systemic lupus erythematosus and rheumatoid arthritis inflamed tissues by immunofluorescence in histological sections | Antibody reports | 2020 | 212 | 101 | |||
| Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers | Rheumatology | 2020 | 334 | 0 | |||
| Monoclonal antibodies RB139 and RB142 recognize citrullinated LL37 by immunofluorescence in histological sections in Systemic lupus erythematosus (SLE) and Rheumatoid arthritis (RA) | Antibody reports | 2020 | 197 | 72 | |||
| IL-17A Dissociates Inflammation from Fibrogenesis in Systemic Sclerosis | Journal of Investigative Dermatology | 2020 | 378 | 2 | |||
| RB137 and RB138 antibodies recognize human cathelicidin LL37 by ELISA | Antibody Reports | 2020 | 365 | 193 | |||
| Quand penser à une myosite et quelle attitude adopter ? | Revue médicale suisse | 2019 | 381 | 540 | |||
| Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis | BMC Nephrology | 2019 | 358 | 197 | |||
| Molecular characterization of monocyte subsets reveals specific and distinctive molecular signatures associated with cardiovascular disease in rheumatoid arthritis | Frontiers in Immunology | 2019 | 361 | 221 | |||
| Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study | Annals of the Rheumatic Diseases | 2019 | 324 | 0 | |||
| Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: a review of the literature | Journal of the American Academy of Dermatology | 2019 | 418 | 886 | |||
| Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus | Rheumatology | 2019 | 482 | 288 | |||
| Anti-C1q antibodies as occurring in systemic lupus erythematosus could be induced by an epstein-barr virus-derived antigenic site | Frontiers in Immunology | 2019 | 301 | 266 | |||
| Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort | Annals of the Rheumatic Diseases | 2019 | 374 | 177 | |||
| CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis | Nature Communications | 2019 | 466 | 232 | |||
| Phenotypes determined by cluster analysis and their survival in the prospective european scleroderma trials and research cohort of patients with systemic sclerosis | Arthritis and Rheumatology | 2019 | 315 | 385 | |||
| Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis | Annals of the Rheumatic Diseases | 2019 | 305 | 141 | |||
| Racial differences in systemic sclerosis disease presentation: a european scleroderma trials and research group study | Rheumatology | 2019 | 319 | 0 | |||
| Limbic encephalitis associated with systemic sclerosis | Multiple sclerosis and related disorders | 2018 | 378 | 0 | |||
| Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database | Clinical and Experimental Rheumatology | 2018 | 348 | 369 | |||
| Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1 | Frontiers in Immunology | 2018 | 520 | 384 | |||
| Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus | Rheumatology | 2018 | 399 | 1 | |||
| Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre study | Arthritis Research and Therapy | 2018 | 396 | 227 | |||
| Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus | PLOS ONE | 2018 | 599 | 373 | |||
| Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus | Rheumatology | 2018 | 432 | 1 | |||
| Allergologie et immunologie clinique | Revue médicale suisse | 2018 | 560 | 190 | |||
| Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus | Frontiers in Immunology | 2018 | 436 | 239 | |||
| Chagas disease and systemic autoimmune diseases among Bolivian patients in Switzerland | Memórias do Instituto Oswaldo Cruz | 2018 | 602 | 231 | |||
| Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study | Arthritis and Rheumatology | 2018 | 312 | 0 | |||
| Successful treatment of refractory lupus nephritis by the sequential use of rituximab and belimumab | Joint bone spine | 2017 | 654 | 1 | |||
| Mesenteric inflammatory veno-occlusive disease of the spleen metasynchronous with two arterial thrombotic events in systemic lupus erythematosus | Lupus | 2017 | 600 | 2 | |||
| Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study | Arthritis Care and Research | 2017 | 417 | 0 | |||
| Matrix Metalloproteinases (MMPs) and cytokines in rheumatology | Matrix Metalloproteinases in health and disease. Sculpting the human body. | 2017 | 327 | 0 | |||
| Is there a role for IL-17 in the pathogenesis of systemic sclerosis? | Immunology Letters | 2017 | 472 | 1 | |||
| The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study | Rheumatology | 2017 | 555 | 0 | |||
| Case Report: Masquerading Large-vessel Giant Cell Arteritis | Optometry and Vision Science | 2017 | 613 | 1 | |||
| Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS) | BMC immunology | 2017 | 596 | 552 | |||
| Basic mechanisms linking inflammation and fibrosis | Systemic Fibroinflammatory Disorders | 2017 | 348 | 0 | |||
| Inflammation and immunity | Scleroderma: from pathogenesis to comprehensive management | 2017 | 311 | 0 | |||
| Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosus | Nephrology, Dialysis, Transplantation | 2017 | 518 | 0 | |||
| Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life | Quality of life research | 2017 | 529 | 1 | |||
| Mapping and predicting mortality from systemic sclerosis | Annals of the Rheumatic Diseases | 2017 | 403 | 1 | |||
| An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey) | Rheumatology International | 2017 | 422 | 0 | |||
| Keratinocyte-derived IL-17E contributes to inflammation in psoriasis | Journal of investigative dermatology | 2016 | 666 | 13 | |||
| A 28-Year-Old Man Presenting With Intractable Dry Cough and a History of Ulcerative Colitis | Chest | 2016 | 616 | 2 | |||
| A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study | Annals of the rheumatic diseases | 2016 | 597 | 2 | |||
| IL-22 capacitates dermal fibroblast responses to TNF in scleroderma | Annals of the rheumatic diseases | 2016 | 709 | 7 | |||
| Sequential, Multimodal Treatment of a Refractory Adult-Onset Still's Disease Complicated by Reactive Hemophagocytic Lymphohistiocytosis | Clinical medical reviews and case reports | 2016 | 484 | 265 | |||
| Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: a cross-sectional study of two cohorts | Lupus | 2015 | 551 | 0 | |||
| Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database | Annals of the rheumatic diseases | 2015 | 460 | 1 | |||
| Diagnostic Dilemma in Sequential Branch Retinal Vein and Artery Occlusion | Optometry and vision science | 2015 | 675 | 1 | |||
| Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab | Annals of hematology | 2015 | 611 | 2 | |||
| The role of the acquired immune response in systemic sclerosis | Seminars in immunopathology | 2015 | 449 | 0 | |||
| Manifestations pulmonaires de la sclérodermie systémique | Revue médicale suisse | 2015 | 490 | 0 | |||
| Vascularites systémiques : nouvelles nomenclature et approches thérapeutiques | Revue médicale suisse | 2014 | 446 | 0 | |||
| Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study | Annals of the rheumatic diseases | 2014 | 450 | 0 | |||
| [Renal disease in ANCA-associated vasculitis] | Revue médicale suisse | 2014 | 496 | 0 | |||
| High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis | PloS one | 2014 | 716 | 370 | |||
| The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland | Schweizerische medizinische Wochenschrift | 2014 | 787 | 761 | |||
| Manifestations digestives de la sclérodermie | Revue médicale suisse | 2014 | 441 | 0 | |||
| Acquired factor XIII deficiency: a therapeutic challenge | Thrombosis and haemostasis | 2013 | 649 | 0 | |||
| Maladies auto-immunes neuromusculaires : diagnostic et prise en charge | Revue médicale suisse | 2013 | 477 | 0 | |||
| Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis | Lupus | 2013 | 605 | 0 | |||
| Acute natural killer cell pneumonia in a patient transplanted with autologous haematopoietic stem cells for systemic sclerosis | Rheumatology | 2013 | 625 | 0 | |||
| Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts | Arthritis research & therapy | 2013 | 554 | 368 | |||
| Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement | Arthritis and rheumatism | 2013 | 650 | 541 | |||
| Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database | Annals of the rheumatic diseases | 2012 | 618 | 0 | |||
| Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosis | Annals of the rheumatic diseases | 2012 | 692 | 0 | |||
| Interleukin-17 expression in neutrophils and Th17 cells in cutaneous T-cell lymphoma associated with neutrophilic infiltrate of the skin | British journal of dermatology | 2012 | 664 | 1 | |||
| Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up | Annals of the rheumatic diseases | 2012 | 627 | 0 | |||
| Response of mucocutaneous lesions to rituximab in a case of melanoma differentiation antigen 5-related dermatomyositis | Dermatology | 2012 | 652 | 1 | |||
| Cardiac involvement in Churg-Strauss syndrome mimicking acute coronary syndrome | Schweizerische medizinische Wochenschrift | 2012 | 676 | 0 | |||
| T cell abnormalities in systemic sclerosis with a focus on Th17 cells | European cytokine network | 2012 | 532 | 0 | |||
| Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease | Arthritis research & therapy | 2011 | 643 | 265 | |||
| Hypereosinophilia in patients with multiple sclerosis treated with natalizumab | Neurology | 2011 | 731 | 0 | |||
| Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis | Arthritis and rheumatism | 2011 | 680 | 0 | |||
| In vivo dioxin favors interleukin-22 production by human CD4+ T cells in an aryl hydrocarbon receptor (AhR)-dependent manner | PloS one | 2011 | 696 | 289 | |||
| Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions | Rheumatology | 2011 | 680 | 1 | |||
| Late adult onset of Langerhans cell histiocytosis mimicking glioblastoma multiforme | Journal of the neurological sciences | 2011 | 644 | 0 | |||
| Le risque cardiovasculaire dans les maladies auto-immunes systémiques | Revue médicale suisse | 2011 | 606 | 0 | |||
| Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique | Clinical and Experimental Rheumatology | 2011 | 521 | 957 | |||
| Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells | European Journal of Immunology | 2010 | 616 | 0 | |||
| Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database | Journal of rheumatology | 2010 | 591 | 1 | |||
| Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database | Annals of the rheumatic diseases | 2010 | 539 | 1 | |||
| Allergo-immunologie | Revue médicale suisse | 2010 | 539 | 0 | |||
| CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells | European Journal of Immunology | 2010 | 684 | 0 | |||
| Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts | Arthritis research & therapy | 2010 | 577 | 1,519 | |||
| Prostaglandin E2: igniting the fire | Immunology and cell biology | 2009 | 509 | 0 | |||
| Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials | Infection and immunity | 2009 | 642 | 0 | |||
| Synovial tissues concentrate secreted APRIL | Arthritis research & therapy | 2009 | 669 | 392 | |||
| In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis | American journal of respiratory cell and molecular biology | 2008 | 766 | 1 | |||
| Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4 | Arthritis and rheumatism | 2008 | 667 | 0 | |||
| Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion | Blood | 2008 | 613 | 0 | |||
| T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis | Current opinion in rheumatology | 2008 | 600 | 0 | |||
| APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa | The Journal of clinical investigation | 2008 | 675 | 774 | |||
| Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis | Arthritis and rheumatism | 2007 | 587 | 479 | |||
| Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database | Annals of the rheumatic diseases | 2007 | 633 | 586 | |||
| Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement | European neurology | 2007 | 1,842 | 685 | |||
| Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts | Rheumatology | 2007 | 488 | 301 | |||
| Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies | Journal of neurology, neurosurgery and psychiatry | 2007 | 532 | 584 | |||
| Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts | Arthritis research & therapy | 2006 | 534 | 219 | |||
| Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts | The FASEB journal | 2006 | 613 | 0 | |||
| Combined antiviral-immunosuppressive treatment in human T-lymphotrophic virus 1-Sjögren-associated myelopathy | Archives of neurology | 2006 | 698 | 551 | |||
| Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behçet disease | Journal of neurology, neurosurgery and psychiatry | 2005 | 577 | 209 | |||
| Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling | European Journal of Immunology | 2005 | 659 | 564 | |||
| Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signalling | Cellular and molecular life sciences | 2005 | 573 | 391 | |||
| Vascular occlusion in serpiginous choroidopathy | British journal of ophthalmology | 2005 | 599 | 273 | |||
| Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? | Arteriosclerosis, thrombosis, and vascular biology | 2005 | 659 | 814 | |||
| Nephrogenic fibrosing dermopathy in a renal transplant recipient with tubulointerstitial nephritis and uveitis | Dermatology | 2004 | 509 | 0 | |||
| Erythema elevatum et diutinum, multiple sclerosis and interferon beta | Dermatology | 2004 | 616 | 90 | |||
| Diagnostic et prise en charge des pathologies rénales de l'enfant | Revue médicale de la Suisse romande | 2004 | 462 | 1 | |||
| Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha | Arthritis and rheumatism | 2003 | 1,039 | 692 | |||
| Thrombose des sinus veineux cérébraux dans la maladie de Behcet : description d'un cas et revue de la littérature | Klinische Monatsblätter für Augenheilkunde | 2003 | 580 | 0 | |||
| Complete remission of pure white cell aplasia associated with thymoma, autoimmune thyroiditis and type 1 diabetes | European journal of haematology | 2003 | 722 | 202 | |||
| Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis | Arthritis and rheumatism | 2002 | 618 | 525 | |||
| Anti-GAD antibodies and breast cancer in a patient with stiff-person syndrome: a puzzling association | European neurology | 2001 | 590 | 583 | |||
| Usefulness of serum eosinophil cationic protein (ECP) in predicting relapse of Churg and Strauss vasculitis | Clinical and Experimental Rheumatology | 2000 | 450 | 0 |
